Venus Concept Inc. VERO) on Wednesday reported a loss of $9.3 million in its third quarter. On a per-share basis, the Toronto-based company said it had a loss of $1.28.
Venus Concept Inc (VERO) is expected to report $-1.23 for 3Q. X4 Pharmaceuticals Inc (XFOR) is expected to report $-0.17 for 3Q. Powered by Kantar Media and Dow Jones. Okta Cut to Hold From Buy by ...
The Equipment Leasing and Finance Association shared the results of this year’s Business Council Steering Committee elections. The committee represents bank-owned or bank-related organizations that ...